We are excited to welcome Dr. Eric Kim as our Vice President of Clinical Sciences.
Dr. Kim is a uro-oncologist at Washington University, specializing in bladder, kidney, and prostate cancers with extensive research work in imaging and biomarkers.
His understanding of the unmet needs in the patient’s cancer journey from diagnosis through treatment selection, along with his expertise in clinical trials will greatly advance EIG's mission of creating diagnostics for early accurate detection and improved treatment of cancer. #earlyisgood #urology #oncology #bladdercancer #prostatecancer
Bladder cancer is one of the most common and expensive to treat cancers in the U.S., but we rely on outdated diagonstic techniques.
Early Is Good is developing single lab test that can detect renal disease earlier and more conveniently than any other test currently available.